Related Experiment Video
Updated: May 8, 2025

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
The Effect of Disclosure on Enacted Stigma Towards Individuals with Inflammatory Bowel Disease
Chalé M Jacks1, Lauren A Stutts2
1Davidson College, Davidson, USA.
Abstract:
Individuals with inflammatory bowel disease (IBD) often experience stigmatization. Disease disclosure has been associated with lower enacted stigma (i.e., engaging in discriminatory treatment), but minimal research has investigated IBD disclosure and enacted stigma experimentally. The present study's aim was to examine the effect of IBD disclosure on enacted stigma in a vignette paradigm. Participants included 244 adults from the United States who were randomized into one of three vignette groups: disclosure of IBD, non-disclosure of IBD, and control (no IBD). Vignettes in both IBD groups depicted a person with frequent bowel movements. Each vignette group contained a workplace, social, and recreational setting. Participants completed measures of enacted stigma, IBD knowledge, and IBD familiarity after reading the vignettes. Participants reported greater propensity to enact stigma in response to vignettes depicting non-disclosure of IBD than vignettes depicting disclosure of IBD or no IBD and for vignettes depicting the recreational setting compared to the workplace and social setting. Enacted stigma was negatively correlated with IBD knowledge. Disease disclosure may result in decreased stigma from others. Furthermore, educating the public about IBD may be beneficial for reducing enacted stigma towards individuals with IBD.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

